Sihuan Pharmaceutical Holdings Group Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sihuan Pharmaceutical Holdings Group Ltd with three other
companies in this sector in China:
Chengdu Kanghong Pharmaceutical Group Co Ltd
sales of 2.79 billion Chinese Renmimbi [US$412.21 million]
of which 100%
was Pharmaceutical Manufacturing),
SSY Group Ltd
(2.66 billion Chinese Renmimbi [US$393.20 million]
of which 96%
was Intravenous Infusion Solution and Others), and
Wuhan Jianmin Pharmaceutical Group Co., Ltd.
(2.71 billion Chinese Renmimbi [US$401.11 million]
of which 69%
During the year ended December of 2017, sales at
Sihuan Pharmaceutical Holdings Group Ltd were 2.75 billion Chinese Renmimbi (US$406.19 million).
decrease of 13.8%
versus 2016, when the company's sales were 3.19 billion Chinese Renmimbi.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Sihuan Pharmaceutical Holdings Group Ltd had sales
of 3.04 billion Chinese Renmimbi.